Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$2.26B |
| 2 |
Carrier Global
CARR
|
+$1.12B |
| 3 |
Chevron
CVX
|
+$922M |
| 4 |
Comcast
CMCSA
|
+$920M |
| 5 |
Philip Morris
PM
|
+$876M |
Top Sells
| 1 |
Alibaba
BABA
|
+$5.5B |
| 2 |
Netflix
NFLX
|
+$1.73B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.61B |
| 4 |
TransDigm Group
TDG
|
+$850M |
| 5 |
Abbott
ABT
|
+$773M |
Sector Composition
| 1 | Healthcare | 20.46% |
| 2 | Technology | 19.55% |
| 3 | Communication Services | 14.69% |
| 4 | Consumer Discretionary | 11.55% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Aptiv
APTV
$18.1B
| $372M | 0.12% |
+4,778,622
| New | +$372M |
|
152
Vertex Pharmaceuticals
VRTX
$100B
| $363M | 0.11% |
1,250,659
-5
| -0% | -$1.45K |
|
153
Ryanair
RYAAY
$30.6B
| $358M | 0.11% |
13,474,868
+4,057,440
| +43% | +$108M |
|
154
Haemonetics
HAE
$2.46B
| $357M | 0.11% |
3,988,003
+1,094,203
| +38% | +$98M |
|
155
Texas Instruments
TXN
$161B
| $356M | 0.11% |
2,805,474
-237
| -0% | -$30.1K |
|
|
IPHI
156
DELISTED
INPHI CORPORATION
IPHI
| $354M | 0.11% |
3,015,074
+376,649
| +14% | +$44.3M |
|
157
NVR
NVR
$22.7B
| $345M | 0.11% |
105,815
+23,753
| +29% | +$77.4M |
|
158
Helen of Troy
HELE
$537M
| $334M | 0.11% |
1,770,286
+102,683
| +6% | +$19.4M |
|
159
Kroger
KR
$44.1B
| $333M | 0.11% |
9,850,839
-6,615,336
| -40% | -$224M |
|
160
Bank of Montreal
BMO
$93.1B
| $333M | 0.11% |
6,252,421
-1,230,723
| -16% | -$65.5M |
|
161
Kellanova
K
$27.6B
| $324M | 0.1% |
5,227,736
+149,894
| +3% | +$9.3M |
|
162
Cannae Holdings
CNNE
$1.14B
| $310M | 0.1% |
7,540,077
+746,520
| +11% | +$30.7M |
|
|
PRAH
163
DELISTED
PRA Health Sciences, Inc.
PRAH
| $309M | 0.1% |
3,176,092
-129,195
| -4% | -$12.6M |
|
164
Johnson & Johnson
JNJ
$425B
| $303M | 0.1% |
2,156,551
-50,725
| -2% | -$7.13M |
|
165
CMS Energy
CMS
$20.9B
| $301M | 0.1% |
5,160,457
+2,072,090
| +67% | +$121M |
|
|
NBL
166
DELISTED
Noble Energy, Inc.
NBL
| $301M | 0.1% |
33,550,545
+5,572,302
| +20% | +$49.9M |
|
167
Centene
CNC
$15.6B
| $300M | 0.09% |
4,720,505
-2,451,410
| -34% | -$156M |
|
168
DraftKings
DKNG
$21.3B
| $290M | 0.09% |
+9,152,440
| New | +$290M |
|
|
COUP
169
DELISTED
Coupa Software Incorporated
COUP
| $283M | 0.09% |
1,022,401
+855,843
| +514% | +$237M |
|
|
PXD
170
DELISTED
Pioneer Natural Resource Co.
PXD
| $280M | 0.09% |
+2,863,047
| New | +$280M |
|
171
Arch Capital
ACGL
$32.6B
| $279M | 0.09% |
9,752,870
+391
| +0% | +$11.2K |
|
172
Altice USA
ATUS
$1.12B
| $278M | 0.09% |
12,351,709
+952
| +0% | +$21.5K |
|
173
Citigroup
C
$185B
| $278M | 0.09% |
5,432,559
+5,092,559
| +1,498% | +$260M |
|
174
McCormick & Company Non-Voting
MKC
$18B
| $274M | 0.09% |
3,055,336
+1,242,864
| +69% | +$111M |
|
175
BWX Technologies
BWXT
$16.2B
| $274M | 0.09% |
4,837,268
-425,353
| -8% | -$24.1M |
|